Skip to main content

Table 2 Patterns of first treatment failure

From: Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)

First failure

No. of patients (%)

CRT group (n = 70)

RT group (n = 70)

No failure

49 (70.0)

32 (45.7)

Loco-regional failure (in field)

8 (11.4)

28 (40.0)

Anastomosis

2 (2.9)

5 (7.1)

Supraclavicular LN

2 (2.9)

10 (14.3)

Superior mediastinal and subcarinal LN

3 (4.3)

14 (20.0)

Lower mediastinal LN

2 (2.9)

3 (4.3)

Abdominal LN

3 (4.3)

3 (4.3)

Distant metastasis

13 (18.6)

18 (25.7)

Lung

3 (4.3)

10 (14.3)

Liver

8 (11.4)

5 (7.1)

Bone

3 (4.3)

6 (8.6)

LN outside radiation field

0 (0.0)

1 (1.4)

Pleura

0 (0.0)

1 (1.4)

Second primary tumor

2 (2.9)

2 (2.9)

  1. *There will be overlapping of patients in various recurrence situations, but the denominator is 70 when we calculating the ratio